Furudate Ken

Affiliation and department：
Research theme for competitive and other funds (2)：

2021 - 2022 New development of cancer treatment by mTOR signal control of cancer-associated fibroblasts in cancer microenvironment
2013 - 2016 Molecular mechanism of the clock gene expression's DEC in tumor microenvironment of oral cancer

Papers (54)：

Matthew Schwede, Katharina Jahn, Jack Kuipers, Linde A Miles, Robert L Bowman, Troy Robinson, Ken Furudate, Hidetaka Uryu, Tomoyuki Tanaka, Yuya Sasaki, et al. Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Leukemia. 2024. 38. 7. 1501-1510
Hidetaka Uryu, Koichi Saeki, Hiroshi Haeno, Chiraag Deepak Kapadia, Ken Furudate, Jyoti Nangalia, Michael Spencer Chapman, Li Zhao, Joanne I Hsu, Chong Zhao, et al. Clonal evolution of hematopoietic stem cells after cancer chemotherapy. bioRxiv : the preprint server for biology. 2024
Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Christopher Jackson, Ashley Rose, Ken Furudate, Bethany Wildeman, Matteo Marchesini, et al. Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nature Communications. 2024. 15. 1. 1203-1203
Matthew Schwede, Katharina Jahn, Jack Kuipers, Linde A Miles, Robert L Bowman, Troy Robinson, Ken Furudate, Hidetaka Uryu, Tomoyuki Tanaka, Yuya Sasaki, et al. Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Research square. 2023
伊藤良平, 古館健, 山崎峻也, 久保田耕世, 今敬生, 田中祐介, 木村博人, 小林恒. 上顎洞に迷入した歯科インプラント体の摘出時期について. 日本口腔インプラント学会誌. 2022. 35. 4. E176-E176

ｍore...

MISC (27)：

松村功貴, 古舘健, 三浦弘行, 藤田大真, 坂下仁菜, 蓮井佳介, 浅利ゆう子, 木下敬子, 田辺壽太郎, 大門眞. テネリグリプチン中止後にCT所見が改善した腸管嚢腫様気腫症の1例. 糖尿病. 2022. 65. 3. 107-107
古舘健, 久保田耕世, 伊藤良平, 成田紀彦, 福田はるか, 福田はるか, 秋山なつみ, 田中祐介, 田中祐介, 田中祐介, et al. A study on QOL after oral cancer treatment. 日本口腔腫瘍学会総会・学術大会プログラム・抄録集. 2022. 40th
久保田耕世, 伊藤良平, 成田紀彦, 古舘健, 福田はるか, 秋山なつみ, 小林恒. Use experience of pegfilgrastim for neutropenia prevention of intra-arterial infusion chemoradiotherapy for oral cancers. 日本口腔腫瘍学会総会・学術大会プログラム・抄録集. 2022. 40th
古舘健, 伊藤良平, 久保田耕世, 小林恒. 包括的シングルセル解析に基づいた口腔癌微小環境における頸部リンパ節転移機構の検討. 頭頸部癌. 2022. 48. 2. 210-210
久保田耕世, 伊藤良平, 古舘健, 小林恒. 口腔癌における予後推定栄養指数と全身性免疫炎症指数の有用性について. 頭頸部癌. 2022. 48. 2. 219-219

ｍore...

Books (2)：

Lectures and oral presentations (8)：

Elucidation of metastatic mechanisms in the oral cancer microenvironment based on comprehensive bioinformatics analysis
(The 67th Congress of the Japanese Society of Oral and Maxillofacial Surgenons 2022)
Emergency Response in Dental Clinics
(Hirosaki Dental Association Monthly Lecture 2022)
Methotrexate-related lymphoproliferative disorder in patients with osteonecrosis of the jaw
(23rd International Conference on Oral and Maxillofacial Surgery (ICOMS))
骨膜由来細胞への張力負荷で誘導される骨芽細胞分化因子とIGFBPsの経時的な発現変動
(日本口腔科学会学術集会プログラム・抄録集 2016)
メトトレキセート関連のリンパ増殖性疾患と顎骨壊死を併発した2例
(日本口腔科学会学術集会プログラム・抄録集 2016)

ｍore...

Education (2)：

Professional career (2)：

Doctor of philosophy (Medicine) (Hirosaki University Graduate School of Medicine)
Doctor of Dental Medicine (Hokkaido University)

Work history (5)：

2023/04 - 現在 Hirosaki University Graduate School of Medicine
2019/04 - 2023/03 弘前大学医学部附属病院歯科口腔外科助教
2019/04 - 2021/01 The University of Texas MD Anderson Cancer Center Department of Genomic Medicine/Leukemia Research Postdoctoral Fellow
2018/04 - 2019/03 Hirosaki University Hospital Oral and Maxillofacial Surgery
2016/04 - 2018/03 Tsugaru General Hospital Oral and Maxillofacial Surgery Chief of Oral Surgery

Awards (2)：

2022/11 - The 67th Congress of the Japanese Society of Oral and Maxillofacial Surgenons Oral Presentation Award Elucidation of metastatic mechanisms in the oral cancer microenvironment based on comprehensive bioinformatics analysis
2017 - 青森県ハンドボール協会青森県ハンドボール協会ベストセブン賞(成年男子)

Association Membership(s) (6)：

日本頭頸部癌学会 , 日本口腔腫瘍学会 , 日本計量生物学会 , 日本口腔顎顔面外傷学会 , 日本口腔科学会 , 日本口腔外科学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page